Le Lézard
Classified in: Health, Business
Subjects: CCA, FVT

Triple-S Management Corporation Schedules Third-Quarter Earnings Release and Webcast


SAN JUAN, Puerto Rico, Oct. 20, 2017 /PRNewswire/ -- Triple-S Management Corporation (NYSE: GTS) today announced that it plans to release financial results for the third quarter ended September 30, 2017 before the market opens on Thursday, November 9, 2017. Roberto García-Rodríguez, President and Chief Executive Officer, and Juan José Román-Jiménez, EVP and Chief Financial Officer, will host a conference call to discuss these results at 9:00 a.m. Eastern Time.  

To participate on the call, please dial 1-855-327-6837 or 1-631-891-4304 at least 5 minutes before start time. The conference call will also be simulcast live on the Internet, and can be accessed by logging onto www.triplesmanagement.com. In addition, a replay will be available through November 23, 2017 by calling 1-844-512-2921 or 1-412-317-6671 and entering passcode 10003713. A replay will also be available on the company's website for 30 days. 

About Triple-S Management Corporation

Triple-S Management Corporation is an independent licensee of the Blue Cross Blue Shield Association. It is one of the leading players in the managed care industry in Puerto Rico. Triple-S Management has the exclusive right to use the Blue Cross Blue Shield name and mark throughout Puerto Rico, the U.S. Virgin Islands, and Costa Rica. With more than 50 years of experience in the industry, Triple-S Management offers a broad portfolio of managed care and related products in the Commercial, Medicare Advantage, and Medicaid markets under the Blue Cross Blue Shield marks. It also provides non-Blue Cross Blue Shield branded life and property and casualty insurance in Puerto Rico. For more information about Triple-S Management, visit www.triplesmanagement.com or contact [email protected].

 

SOURCE Triple-S Management Corporation


These press releases may also interest you

at 09:50
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...

at 09:47
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...

at 09:45
Pleio, Inc. and FountainRx announce their partnership to provide a concierge-level experience to specialty pharmacy patients. The two companies are launching a program to provide patients with human-driven support as they onboard onto their specialty...

at 09:45
JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Moleculin Biotech , a clinical stage pharmaceutical company with a...

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...



News published on and distributed by: